Oxford-led research project receives ARIA funding for broad-spectrum antiviral medicines
Summary
A research project led by Professor Jan Rehwinkel at Oxford is one of three Oxford-led projects funded by the UK's Advanced Research and Invention Agency (ARIA) under its £57 million Sustained Viral Resilience programme. The programme aims to develop Sustained Innate Immunoprophylactics (SIIPs) — a new class of medicines offering durable, broad-spectrum protection against respiratory viruses.
Source
bskyOxford-led research project receives ARIA funding for broad-spectrum antiviral medicinesimm.ox.ac.ukKey quotes
· 3 pulledA research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses
The projects are supported as part of ARIA's Sustained Viral Resilience programme, a £57 million initiative led by Programme Director Brian Wang
11 funded teams will explore and unlock ways to create sustained innate immunoprophylactics (SIIPs) - a new class of medicines that provide durable, broad-spectrum protection
You might also wanna read
Exploring ARIA: The UK's Pursuit of Scientific Revolutions
The UK's Advanced Research and Invention Agency (ARIA) is compared to a 'UK DARPA' with DARPA-inspired features like term-limited program ma
asimov.press·1y ago
Eindhoven University Students Develop Modular Electric Car Designed for Easy Self-Repair
A team of students from Eindhoven University of Technology has developed a prototype modular electric car called ARIA that features a built-
Dezeen·5mo ago
Oxford selected to host new UK government-backed AI research lab (BOLD)
The University of Oxford has been selected to host a new, cross-university government-backed UK AI Research Lab called the British Open-ende
ox.ac.uk·1d ago
Intercept: A $500M push to eliminate respiratory infections like colds and flu
A century ago, waterborne diseases like cholera and typhoid were considered inevitable until clean water infrastructure and pharmaceutical a
interceptfund.substack.com·1d ago
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus
bbc.com·4mo ago
Intercept: A $500M initiative to eliminate respiratory infections like colds and flu
A deep analysis of the historical parallels between waterborne diseases (cholera, typhoid) that were eliminated through infrastructure and p
blog.interceptfund.com·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.